Holmusk is a global health technology company transforming behavioral health through real-world data. Its NeuroBlu Database, developed with leading health systems, includes data from over 36 million patients across 20+ years of care—making it the richest, most research-ready resource for neuropsychiatric research and treatment. By curating longitudinal clinical data, Holmusk helps health systems unlock insights into population trends, treatment outcomes, and care quality. Partners benefit from advanced analytics, collaborative research, and tools that support precision mental health care and operational innovation.